Who
Raffi Asadorian
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Talphera; Chief Financial Officer, Amyris.
In numbers
- Trades disclosed
- 59
- Buys
- 8
- Sells
- 1
- Bought
- $175K
- Sold
- $119
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 20 Jan 2015
- Last trade
- 2 Apr 2026
- Last filed
- 3 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Apr 2026filed 3 Apr 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $1,7652,444 at $0.7223 | filing |
| 2 Apr 2026filed 3 Apr 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $1,7602,444 at $0.72 | filing |
| 14 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $2,3272,933 at $0.7934 | filing |
| 14 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $2,3172,933 at $0.79 | filing |
| 12 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Bought | $37K45,000 at $0.8123 | filing |
| 12 Feb 2026filed 20 Feb 2026 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —260,000 at $0.00 | filing |
| 12 Feb 2026filed 20 Feb 2026 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —260,000 at $0.00 | filing |
| 12 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Bought | $36K45,000 at $0.81 | filing |
| 10 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $801958 at $0.8361 | filing |
| 10 Feb 2026filed 20 Feb 2026 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $805958 at $0.84 | filing |
| 2 Apr 2025filed 3 Apr 2025 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 2 Apr 2025filed 3 Apr 2025 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 14 Feb 2025filed 18 Feb 2025 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $2,1743,245 at $0.67 | filing |
| 11 Feb 2025filed 12 Feb 2025 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $6571,060 at $0.62 | filing |
| 10 Feb 2025filed 12 Feb 2025 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $6671,059 at $0.63 | filing |
| 2 Dec 2024filed 2 Dec 2024 | TLPH TalpheraBiotechnology | SEC FORM 4 Sold | $119155 at $0.77 | filing |
| 3 Mar 2024filed 4 Mar 2024 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $725558 at $1.30 | filing |
| 14 Feb 2024filed 27 Feb 2024 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | —108,000 at $0.00 | filing |
| 14 Feb 2024filed 27 Feb 2024 | TLPH TalpheraBiotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
| 11 Feb 2024filed 13 Feb 2024 | TLPH TalpheraBiotechnology | SEC FORM 4 Code F | $985895 at $1.10 | filing |
News
Evolus (NASDAQ:EOLS) & Talphera (NASDAQ:TLPH) Financial ComparisonTLPH · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Raffi Asadorian; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.